Wendy Rodriguez
Family · Port Jervis, NYNPI 1760925689
Payments from drug & device makers
Across 131 payments — averaging $26.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$632
- GSK$564
- Lilly USA, LLC$350
- Gilead$322
- Viiv Healthcare Company$292
- Dexcom, Inc.$160
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $632 |
| GSK | 28 | $564 |
| Lilly USA, LLC | 7 | $350 |
| Gilead | 9 | $322 |
| Viiv Healthcare Company | 4 | $292 |
| Dexcom, Inc. | 1 | $160 |
| AbbVie | 6 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $121 |
| AstraZeneca | 8 | $112 |
| Amarin Pharma, Inc. | 7 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Boehringer Ingelheim | 5 | $76 |
| Johnson & Johnson | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Pfizer | 4 | $58 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| Exact Sciences | 2 | $52 |
| Phathom Pharmaceuticals, Inc. | 1 | $34 |
| Merck | 2 | $29 |
| Amneal Pharmaceuticals LLC | 2 | $26 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Abbott | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$250
- DEXCOM G7 GSS (161)$160
- DEXCOM STELO GLUCOSE BIOSENSOR$160
- AREXVY$125
- Biktarvy$125
- Wegovy$125
- CABENUVA$125
- DOVATO$125
- Saxenda$125
- NURTEC ODT$121
- RYBELSUS$116
- TRELEGY ELLIPTA$101
How this compares
$3,412 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $42,041 |
| JardianceEmpagliflozin | 31 | $39,818 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $32,233 |
| OzempicSemaglutide | 23 | $27,022 |
| FarxigaDapagliflozin Propanediol | 12 | $19,022 |
| TrulicityDulaglutide | 14 | $18,498 |
| EliquisApixaban | 25 | $17,795 |
| JanuviaSitagliptin Phosphate | 13 | $12,523 |
| MounjaroTirzepatide | 11 | $11,573 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,243 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 90 | $3,231 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,703 |
| Metoprolol Succinate | 91 | $1,196 |
| Atorvastatin Calcium | 168 | $1,148 |
| Levothyroxine Sodium | 95 | $845 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $322 | $42,04111 claims |
| Boehringer IngelheimJardiance | $76 | $39,81831 claims |
| GSKTrelegy Ellipta | $564 | $32,23326 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $350 | $30,07025 claims |
| Novo NordiskOzempic | $632 | $27,02223 claims |
| AstraZenecaFarxiga | $112 | $19,02212 claims |
| PfizerEliquis | $58 | $17,79525 claims |
| MerckJanuvia | $29 | $12,52313 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $26 | $84595 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,883 family providers in New York.
Other family in Port Jervis
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.